Technology

Energy

Filter By:

Type

Fellow

Research Team

Use comma-separated ID numbers for each author

Support the Hoover Institution

Join the Hoover Institution's community of supporters in advancing ideas defining a free society.

Support Hoover

Interviews

John Yoo: Twitter Wades Into Controversy With Fact-Check Label For Trump Tweet

interview with John Yoovia Fox News
Thursday, May 28, 2020

Hoover Institution fellow John Yoo discusses Twitter fact checking President Trump as well as the overall political bias in social media.

Analysis and Commentary

The Doctrine Of Media Untruth

by Victor Davis Hansonvia American Greatness
Sunday, May 24, 2020

When knowledge, wisdom, independent thought, even basic competence were no longer requisites for success, then the media naturally slid into mediocrity, and mastered networking and obsequiousness instead of valuing independence.

Uncommon Knowledge new logo 1400 x 1400
Blank Section (Placeholder)

How Innovation Works, with Matt Ridley

interview with Matt Ridleyvia Uncommon Knowledge
Monday, May 18, 2020

AUDIO ONLY

The impact of the COVID-19 crisis on the world’s economies, the real story of Thomas Edison and why he was one of the greatest innovators in human history, why China may not be the threat it appears to be (at least not technologically), and some predictions as to what the world may look like in 2050.

Blank Section (Placeholder)Featured

How Innovation Works, With Matt Ridley

interview with Matt Ridleyvia Uncommon Knowledge
Monday, May 18, 2020

Matt Ridley discusses his new book is How Innovation Works, as well as the impact of the COVID-19 crisis on the world’s economies, the real story of Thomas Edison and why he was one of the greatest innovators in human history, why China may not be the threat it appears to be (at least not technologically), and some predictions as to what the world may look like in 2050. 

FeaturedBlank Section (Placeholder)

Rights And Regulation In The Internet Age

by Peter Berkowitz quoting Jack Goldsmithvia Real Clear Politics
Sunday, May 17, 2020

In Book I of “Plato’s Republic,” Socrates observes that master doctors serve as our guardians against the most dangerous diseases while possessing the greatest skills for surreptitiously producing them. The quality of doctors’ character makes all the difference.

Starving (or Fattening) the Golden Goose: Generic Entry and the Incentives for Early-Stage Pharmaceutical Innovation

by Lee Branstetter, Chirantan Chatterjee, Eric Higginsvia IP2 Working Paper Series
Tuesday, May 9, 2017

Generic penetration in the U.S. pharmaceutical market has increased, providing significant gains in consumer surplus. What impact has this had on the rate and direction of pharmaceutical innovation? While the overall level of drug development activity has increased, our estimates suggest a sizable, robust, negative relationship between generic penetration and early-stage pharmaceutical innovation.

A Quality-Adjusted Price Index for Colorectal Cancer Drugs

by Claudio Lucarelli, Sean Nicholsonvia IP2 Working Paper Series
Friday, April 7, 2017

The average price of treating a colorectal cancer patient with chemotherapy increased from about $100 in 1993 to $36,000 in 2005, due largely to the approval and widespread use of five new drugs between 1996 and 2004. We examine whether the substantial increase in spending has been worth it. 

Has the Academy Led Patent Law Astray?

by Jonathan M. Barnettvia IP2 Working Paper Series
Friday, April 7, 2017

Scholarly commentary widely asserts that technology markets suffer from a triplet of adverse effects arising from the strong patent regime associated with the establishment of the Court of Appeals for the Federal Circuit in 1982: “patent thickets” that burden innovation with transaction and litigation costs; “patent holdup” resulting in excessive payouts to opportunistic patent holders; and “royalty stacking” resulting in exorbitant patent licensing fees.

Alternative Remedies in Standard Essential Patents Disputes

by Igor Nikolicvia IP2 Working Paper Series
Friday, April 7, 2017

The possibility to seek and obtain injunctions for the infringement of Standard Essential Patents (SEPs) is limited in both the US and the EU. The reasons for restricting the use of injunctions is due to concern of patent holdup, i.e. the possibility of SEP holder to force standard-implementers to accept onerous licensing terms, exceeding patent’s true economic value, as well as seeing injunctions as incompatible with the commitment given by the patent holder that it will license its SEPs on fair, reasonable and non-discriminatory (FRAND) terms.

Patent Applications

Why Incentives for “Patent Holdout” Threaten to Dismantle FRAND, and Why It Matters

by Richard A. Epstein, Kayvan B. Noroozivia IP2 Working Paper Series
Wednesday, January 18, 2017

An increasing number of judges, legislators and scholars wrongly believe that the FRAND commitment was principally created to advance the interests of technology implementers, and should be interpreted by giving a presumptive preference toward those interests. That premise has led courts to take a categorically hostile view toward awarding injunctions against implementers under all circumstances. 

Pages

Energy Policy Task Force


The Task Force on Energy Policy addresses energy policy in the United States and its effects on our domestic and international political priorities, particularly our national security.